Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581838 · ClinicalTrials.gov registry record
Eating With Eosinophilic Esophagitis (EoE)
A clinical trial of Eosinophilic Esophagitis (EoE), sponsored by Mayo Clinic.
- Completed
- Registry status
- 31
- Enrollment target
- 1
- Study location
NCT03581838 is a study of Eosinophilic Esophagitis (EoE) that has completed, run by Mayo Clinic. The registered enrollment target is 31 participants, below the 123-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03581838, a study of Eosinophilic Esophagitis (EoE), has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
Is there a difference in the eating process for patients with active Eosinophilic Esophagitis (EoE) and those with inactive disease?
Conditions Studied
Interventions
- BEHAVIORAL Observed eating session
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-05-24 |
| Est. Completion | 2019-07-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03581838
The ClinicalTrials.gov registry entry for NCT03581838 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 123-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (75% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eosinophilic Esophagitis (EoE) appearing as the primary indexed condition, and to 1 intervention - of which Observed eating session is the first listed.
NCT03581838 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03581838 about?
NCT03581838 is a clinical study titled "Eating With Eosinophilic Esophagitis (EoE)". Is there a difference in the eating process for patients with active Eosinophilic Esophagitis (EoE) and those with inactive disease?
What is the current status of trial NCT03581838?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2018-05-24. Estimated completion is 2019-07-23.
What conditions does trial NCT03581838 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis (EoE).
What interventions are being tested in trial NCT03581838?
The interventions under investigation include: Observed eating session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03581838?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03581838 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis (EoE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surface EMG Testing on Swallowing in EoE Patients
RECRUITING
-
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
RECRUITING
-
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
RECRUITING · Phase 4
-
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
RECRUITING · Phase 3
-
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
RECRUITING
-
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.